# Preventing Depression Recurrence in Diabetes

> **NCT00374426** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 262 (—)

## Conditions studied

- Major Depression
- Diabetes

## Interventions

- **DRUG:** sertraline

## Key facts

- **NCT ID:** NCT00374426
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 262 (—)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374426, "Preventing Depression Recurrence in Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00374426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*